Liminatus Pharma, Inc. - 8-K Filing
Liminatus Pharma fails to regain Nasdaq compliance under Bid Price Rule and faces potential delisting (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $LIMN